AC
ATRC icon

Armistice Capital’s AtriCure ATRC Stock Holding History

Armistice Capital’s Portfolio ATRC Stock Details ATRC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-27,928
Closed -$1.22M – 306
2023
Q3 		$1.22M Buy
+27,928
New +$1.36M 0.02% 142
2023
Q2 		– Sell
-5,899
Closed -$245K – 226
2023
Q1 		$245K Buy
+5,899
New +$245K ﹤0.01% 179

Other funds holding ATRC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return

Armistice Capital's ATRC Position: Q4 2023 in Review

Armistice Capital sold out of AtriCure (ATRC) in Q4 2023, closing a stake of 27,928 shares — an estimated $1.22M sold.

Armistice Capital first reported a position in ATRC in Q1 2023 and held it in 2 quarters. The position peaked at $1.22M in Q3 2023. 233 funds tracked by Wall St. Rank hold ATRC as of Q4 2023.

  • Armistice Capital reported no remaining AtriCure position as of Q4 2023 after selling out during the quarter.
  • Armistice Capital sold 27,928 AtriCure shares in Q4 2023, an estimated $1.22M.
  • Armistice Capital first reported a position in AtriCure in Q1 2023 and held it in 2 quarters.
  • Armistice Capital's AtriCure position peaked at $1.22M in Q3 2023.
  • 233 funds tracked by Wall St. Rank held AtriCure as of Q4 2023.

Based on Armistice Capital's 13F filing for Q4 2023, filed 13 Feb 2024.